查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375863

介入性心臟病学设备市场规模、份额和趋势分析报告：2023-2030 年按产品、地区和细分市场分類的趋势

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

介入性心臟病学设备市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球介入性心臟病设备市场规模预计将达到 223.5 亿美元。

预计2023年至2030年该市场将以7.2%的年复合成长率扩张。由于冠状动脉介入手术的优惠报销政策、全球心血管疾病（CVD）和糖尿病盛行率的上升以及市场上新产品线的推出，对介入性心臟病学设备的需求正在上升。心血管疾病是全世界死亡和罹患率的主要原因之一。冠状动脉疾病和先天性心臟疾病是世界各地流行的主要心血管疾病。

此外，吸烟、久坐、用餐不当等不健康的生活方式也会导致糖尿病。心导管插入术、血管成形术和经皮冠状动脉介入治疗（PCI）是治疗心血管疾病的主要手术。由于糖尿病是心血管疾病的主要原因之一，预计糖尿病患者数量的增加将在预测期内大幅增加对介入性心臟病学设备的需求。儘管市场预计在未来年度将扩大，但由于医疗设备价格高昂，成长可能会放缓，特别是在保险覆盖范围不足的新兴经济体。

介入性心臟病学市场报告亮点

  • 冠脉支架领域将在2022年以64.6%的销售份额占据市场主导地位。 DES 占冠状动脉支架部门销售额的大部分
  • 冠状动脉支架的技术进步，例如分叉支架的开发和生物分解性材料的使用，导致了更有效的CVD治疗和改善的结果。每家公司都积极参与产品开发、合作伙伴关係和策略联盟。上述因素预计将在预测期内推动产业成长。
  • 预计亚太地区在预测期内将以 7.9% 的最快年复合成长率成长。这种增长是由于多种因素造成的，包括冠状动脉疾病（CAD）罹患率的增加以及针对这种疾病的筛检措施的改进。
  • 由于多家公司的存在，市场变得分散。因此，预计未来年度竞争将会加剧。市场参与企业正在采取各种策略倡议，例如联盟、销售和行销活动、併购、服务扩展、整合产品和产品发布，以增强其在市场中的影响力。

目录

第1章调查方法与范围

第2章执行摘要

第3章介入性心臟病学设备市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 心臟介入设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章心臟介入器材市场：产品预估及趋势分析

  • 心臟介入器材市场：重点
  • 心臟介入器材市场：2022年及2030年产品趋势及市场占有率分析
  • 冠状动脉支架
  • PTCA球囊导管
  • 附属装置
  • 血管成像导管和压力导丝

第5章心臟介入器材市场：区域估算及趋势分析

  • 区域展望
  • 按地区分類的心臟介入器材市场：要点
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018 年至 2030 年 MEA 市场估计与预测
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott Laboratories
    • Medtronic
    • Boston Scientific
    • Spectranetics
    • Cardinal Health
    • Philips Healthcare
    • Terumo
    • Alvimedica
    • Teleflex Medical
    • B. Braun
    • Biosensors International
    • Meril Life Sciences
    • BIOTRONIK
    • ACIST Medical Systems
    • ASAHI INTECC
    • CID Vascular
    • Cook Medical
    • Medinol
    • Merit Medical Systems
    • NuMED
    • OpSens
    • Vascular Solutions
    • Zeon Medical
Product Code: 978-1-68038-122-1

Interventional Cardiology Devices Market Growth & Trends:

The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Interventional Cardiology Devices Market Report Highlights:

  • The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.
  • Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
  • Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
  • The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Interventional Cardiology Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Interventional Cardiology Devices Market: Key Takeaways
  • 4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Coronary Stents
    • 4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. DES
      • 4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. BMS
      • 4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. BRS
      • 4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. PTCA Balloon Catheters
    • 4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Normal
      • 4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Specialty
      • 4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. DCB
      • 4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Accessory Devices
    • 4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. PTCA guidewires
      • 4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Diagnostic catheters
      • 4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. PTCA guiding catheters
      • 4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Introducer sheaths
      • 4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Intravascular imaging catheters and pressure guidewires
    • 4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Abbott Laboratories
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Spectranetics
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Cardinal Health
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Philips Healthcare
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Terumo
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Alvimedica
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex Medical
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. B. Braun
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Biosensors International
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Meril Life Sciences
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. BIOTRONIK
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. ACIST Medical Systems
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. ASAHI INTECC
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives
    • 6.2.16. CID Vascular
      • 6.2.16.1. Company overview
      • 6.2.16.2. Financial performance
      • 6.2.16.3. Product benchmarking
      • 6.2.16.4. Strategic initiatives
    • 6.2.17. Cook Medical
      • 6.2.17.1. Company overview
      • 6.2.17.2. Financial performance
      • 6.2.17.3. Product benchmarking
      • 6.2.17.4. Strategic initiatives
    • 6.2.18. Medinol
      • 6.2.18.1. Company overview
      • 6.2.18.2. Financial performance
      • 6.2.18.3. Product benchmarking
      • 6.2.18.4. Strategic initiatives
    • 6.2.19. Merit Medical Systems
      • 6.2.19.1. Company overview
      • 6.2.19.2. Financial performance
      • 6.2.19.3. Product benchmarking
      • 6.2.19.4. Strategic initiatives
    • 6.2.20. NuMED
      • 6.2.20.1. Company overview
      • 6.2.20.2. Financial performance
      • 6.2.20.3. Product benchmarking
      • 6.2.20.4. Strategic initiatives
    • 6.2.21. OpSens
      • 6.2.21.1. Company overview
      • 6.2.21.2. Financial performance
      • 6.2.21.3. Product benchmarking
      • 6.2.21.4. Strategic initiatives
    • 6.2.22. Vascular Solutions
      • 6.2.22.1. Company overview
      • 6.2.22.2. Financial performance
      • 6.2.22.3. Product benchmarking
      • 6.2.22.4. Strategic initiatives
    • 6.2.23. Zeon Medical
      • 6.2.23.1. Company overview
      • 6.2.23.2. Financial performance
      • 6.2.23.3. Product benchmarking
      • 6.2.23.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India interventional cardiology devices market, by product, 2018 - 2030, (USD Million)
  • Table 21 Australia interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait interventional cardiology devices market, by product, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Interventional cardiology devices: Market outlook
  • Fig. 9 Interventional cardiology devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Interventional cardiology devices market driver impact
  • Fig. 15 Interventional cardiology devices market restraint impact
  • Fig. 16 Interventional cardiology devices market strategic initiatives analysis
  • Fig. 17 Interventional cardiology devices market: Product movement analysis
  • Fig. 18 Interventional cardiology devices market: Product outlook and key takeaways
  • Fig. 19 Coronary stents market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 20 DES market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 BMS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BRS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 PTCA balloon catheters market estimates and forecasts, (USD million) 2018 - 2030
  • Fig. 24 Normal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Specialty market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 DCB market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Accessory devices market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 28 PTCA guidewires market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 29 Diagnostic catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 PTCA guiding catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Introducer sheaths market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Intravascular imaging catheters and pressure guidewire market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global interventional cardiology devices market: Regional movement analysis
  • Fig. 34 Global interventional cardiology devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 -2030, (USD million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)